Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inhibiting Stromal Class I HDACs Curbs Pancreatic Cancer Progression

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.12.557260Source: DataRank Database

Inhibiting Stromal Class I HDACs Curbs Pancreatic Cancer Progression is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (45)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Tae Gyu Oh ORCID,Nasun Hah ORCID,Hervé Tiriac ORCID,Yu Shi ORCID,Morgan Truitt ORCID

Live enrichment

PubMed:37745372 OpenAlex:https://openalex.org/W4386741797

National Institutes of Health

Grant: 5F32CA217033-02

Epigenetic therapy for pancreatic cancer

National Institutes of Health

Grant: 5R01CA220468-05

Organic nanoparticles for dual MRI-guided therapeutic selection and ovarian cancer drug delivery

National Institutes of Health

Grant: 1R01CA082683-01

SIGNAL TRANSDUCTION BY TYROSINE PHOSPHORYLATION

National Institutes of Health

Grant: 5T32CA009370-06

CELL REGULATION DIFFERENTIATION AND CANCER

greenLicense: CC BY

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/09/14/2023.09.12.557260.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.09.12.557260

repositoryhttps://doi.org/10.1101/2023.09.12.557260

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37745372

Fields of Study

Histone Deacetylase Inhibitors ResearchPancreatic and Hepatic Oncology ResearchEpigenetics and DNA Methylation03 medical and health sciences0302 clinical medicine

Keywords

Stromal cellCancer researchEpigeneticsPancreatic cancerTumor microenvironmentStromaCancer-Associated FibroblastsBiologyCrosstalkParacrine signallingVorinostatDesmoplasiaHistone deacetylaseCancerCell biologyHistoneImmunologyGeneticsCarcinogenesisScienceOncology and Carcinogenesis610ArticleCell LineMiceRare DiseasesCell Line, Tumor2.1 Biological and endogenous factorsAnimalsAetiologyPancreasTumorBiomedical and Clinical SciencesCarcinomaQFibroblastsPancreatic NeoplasmsPancreatic DuctalDigestive DiseasesCarcinoma, Pancreatic Ductal

Sustainable Development Goals

SDG 0: Good health and well-being